Understanding Adjuvant Therapy Options
This resource is intended to help you understand your treatment options for early-stage lung cancer as you and your healthcare team make important decisions about your treatment. You will find perspectives from both lung cancer experts and patients. This program was created as a collaboration between Neil Love, MD, a medical oncologist and president of the education group Research To Practice, and the National Lung Cancer Partnership, a lung cancer advocacy organization.
What is Adjuvant Therapy?
Adjuvant therapy is a medical term for additional treatment that is added to primary treatment (for example, chemotherapy after a surgery). Research has shown that adjuvant therapy helps people with stage II and IIIA lung cancer live longer, and may also help some people with stage IB disease.
 |
Interviews with Survivors and Patients
Find out what other patients and survivors have experienced with treatments, side effects, recovery, clinical trials and coping with lung cancer.
Featuring Interviews with people who have received adjuvant therapy after lung cancer surgery:
Patient 1 had stage IB lung cancer
Patient 2 is in treatment for early-stage lung cancer
Patient 3 had stage II lung cancer and participated in a clinical trial
Patient 4 had stage IIIA lung cancer and participated in a clinical trial
|
 |
|
 |
Interviews with Health Care Professionals
Find out why oncologists recommend certain lung cancer adjuvant therapies – including clinical trials – and how health care providers talk with patients about their options.
Featuring Interviews with:
Heather Wakelee, MD
Stanford Cancer Center
Joan H Schiller, MD
University of Texas Southwestern Medical Center
Beth Eaby, MSN, CRNP, OCN
Abramson Cancer Center
|
|
|
